Literature DB >> 9474183

A model for the number of cores per prostate biopsy based on patient age and prostate gland volume.

A R Vashi1, K J Wojno, B Gillespie, J E Oesterling.   

Abstract

PURPOSE: The systematic sextant biopsy is currently the gold standard for the tissue diagnosis of prostate cancer. However, it is unknown whether this 6 core approach provides optimal sampling of all prostate glands in men of all ages. The goal of the current study was to determine the appropriate number of cores per prostate biopsy based on patient age and prostate gland volume.
MATERIALS AND METHODS: Patient age and tumor volume doubling time were used to calculate life threatening, clinically significant tumor volumes at diagnosis for 5-year intervals of patient age. A mathematical model was created to determine the minimum number of cores necessary to identify these life threatening tumor volumes in prostate glands 10 to 80 cm.3 without detecting clinically insignificant cancers.
RESULTS: Younger men and men with larger prostate glands require more than 6 cores to ensure the diagnosis of life threatening prostate cancer. These prostates are currently under sampled by sextant biopsy. In a select group of older men who require fewer than 6 cores sextant biopsy may over sample these prostates and lead to over treatment.
CONCLUSIONS: The standard sextant biopsy provides optimal sampling of only a minority of prostate glands. An approach to prostate biopsy based on patient age and prostate gland volume maximizes the detection of clinically significant prostate cancer.

Entities:  

Mesh:

Year:  1998        PMID: 9474183

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  [Diagnostics and therapy of localized prostate cancer: a problem-oriented account].

Authors:  C Weber
Journal:  Radiologe       Date:  2011-11       Impact factor: 0.635

2.  Follow-up of men obtaining a six-core versus a ten-core benign prostate biopsy 7 years previously.

Authors:  Clemens Brossner; Stefan Madersbacher; Phillip de Mare; Anton Ponholzer; Bader Al-Ali; Michael Rauchenwald
Journal:  World J Urol       Date:  2005-12-03       Impact factor: 4.226

Review 3.  Biopsy standards for detection of prostate cancer.

Authors:  Bob Djavan; Markus Margreiter
Journal:  World J Urol       Date:  2007-03-07       Impact factor: 4.226

4.  Using biopsy to detect prostate cancer.

Authors:  Shahrokh F Shariat; Claus G Roehrborn
Journal:  Rev Urol       Date:  2008

5.  How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?

Authors:  Ege Can Serefoglu; Serkan Altinova; Nevzat Serdar Ugras; Egemen Akincioglu; Erem Asil; M Derya Balbay
Journal:  Can Urol Assoc J       Date:  2013-05-13       Impact factor: 1.862

6.  Prostate cancer diagnostics: innovative imaging in case of multiple negative biopsies.

Authors:  Tillmann Loch
Journal:  World J Urol       Date:  2011-07-09       Impact factor: 4.226

7.  Transperineal prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsies.

Authors:  Gordon R Kepner; Jeremy V Kepner
Journal:  Theor Biol Med Model       Date:  2010-06-17       Impact factor: 2.432

Review 8.  Watchful waiting versus active surveillance: appropriate patient selection.

Authors:  Marc A Dall'Era; Christopher J Kane
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

Review 9.  [Differential therapy of prostate cancer].

Authors:  T Jäger; H Rübben; C Börgermann
Journal:  Internist (Berl)       Date:  2007-12       Impact factor: 0.743

10.  Effect of dimensions and volume of the prostate on cancer detection rate of 12 core prostate biopsy.

Authors:  Eriz Ozden; Ahmet Tuncay Turgut; Halit Talas; Onder Yaman; Orhan Göğüş
Journal:  Int Urol Nephrol       Date:  2007-02-15       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.